Charles Schwab’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-92,904
| Closed | -$1.06M | – | 3548 |
|
2020
Q4 | $1.06M | Buy |
92,904
+1,461
| +2% | +$16.7K | ﹤0.01% | 2753 |
|
2020
Q3 | $631K | Buy |
91,443
+613
| +0.7% | +$4.23K | ﹤0.01% | 2815 |
|
2020
Q2 | $593K | Sell |
90,830
-1,249
| -1% | -$8.15K | ﹤0.01% | 2769 |
|
2020
Q1 | $609K | Buy |
92,079
+1,758
| +2% | +$11.6K | ﹤0.01% | 2646 |
|
2019
Q4 | $937K | Buy |
90,321
+990
| +1% | +$10.3K | ﹤0.01% | 2618 |
|
2019
Q3 | $565K | Sell |
89,331
-14,560
| -14% | -$92.1K | ﹤0.01% | 2754 |
|
2019
Q2 | $773K | Buy |
103,891
+23,760
| +30% | +$177K | ﹤0.01% | 2661 |
|
2019
Q1 | $493K | Sell |
80,131
-4,076
| -5% | -$25.1K | ﹤0.01% | 2775 |
|
2018
Q4 | $971K | Sell |
84,207
-1,490
| -2% | -$17.2K | ﹤0.01% | 2547 |
|
2018
Q3 | $1.86M | Buy |
85,697
+14,370
| +20% | +$311K | ﹤0.01% | 2447 |
|
2018
Q2 | $1.13M | Buy |
71,327
+15,675
| +28% | +$247K | ﹤0.01% | 2556 |
|
2018
Q1 | $1.05M | Buy |
55,652
+1,872
| +3% | +$35.3K | ﹤0.01% | 2500 |
|
2017
Q4 | $936K | Sell |
53,780
-11,881
| -18% | -$207K | ﹤0.01% | 2528 |
|
2017
Q3 | $983K | Buy |
65,661
+26,529
| +68% | +$397K | ﹤0.01% | 2512 |
|
2017
Q2 | $726K | Buy |
39,132
+285
| +0.7% | +$5.29K | ﹤0.01% | 2569 |
|
2017
Q1 | $656K | Buy |
38,847
+2,565
| +7% | +$43.3K | ﹤0.01% | 2553 |
|
2016
Q4 | $773K | Buy |
36,282
+2,310
| +7% | +$49.2K | ﹤0.01% | 2504 |
|
2016
Q3 | $621K | Buy |
33,972
+10,563
| +45% | +$193K | ﹤0.01% | 2548 |
|
2016
Q2 | $679K | Buy |
+23,409
| New | +$679K | ﹤0.01% | 2480 |
|